Evolent Health, Inc. EVH Specialty Technology and Services Suite — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s specialty technology and services suite — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s specialty technology and services suite — revenue?
- Evolent Health, Inc. (EVH) reported specialty technology and services suite — revenue of $80.8M in Q1 2026.
- How has Evolent Health, Inc.'s specialty technology and services suite — revenue changed year-over-year?
- Evolent Health, Inc.'s specialty technology and services suite — revenue decreased by 2.4% year-over-year, from $82.82M to $80.8M.
- What is the long-term trend for Evolent Health, Inc.'s specialty technology and services suite — revenue?
- Over 4 years (2021 to 2025), Evolent Health, Inc.'s specialty technology and services suite — revenue has grown at a 69.8% compound annual growth rate (CAGR), from $42.5M to $353.23M.
- What does specialty technology and services suite — revenue mean?
- This metric represents the total revenue generated from the company's specialized technology platform and associated services designed to manage clinical care pathways. It reflects the financial performance of the business unit focused on delivering value-based care infrastructure, including specialty management solutions for complex medical conditions. Growth in this segment indicates successful adoption of the company's clinical management tools by health systems and payers.